011-4988-5050
customer.care@lalpathlabs.com
Ovarian Cancer
Home > Ovarian Cancer
- Overview
- Symptoms
- Risk Factor
- Diagnosis
- Stages
- Our Offerings
Overview
Early-stage ovarian cancer, in which the disease is confined to the ovary, is more likely (about 90-95%) to be treated successfully. However, early ovarian cancer is not easy to detect. Unfortunately, Ovarian cancer often goes undetected until it has spread within the pelvis and abdomen. At this late stage, ovarian cancer is more difficult to treat and is frequently fatal.
Incidence
Ovarian cancer is the fifth-leading cause of cancer death in women. Overall, it makes up about 3% of all cancers in women.- Older women are at higher risk of developing ovarian cancer. More number of cases occur in women who are over 60 years of age.
Symptoms of Ovarian Cancer
Certain factors were identified that are associated with an increased risk of Ovarian cancer:
Swollen abdomen or bloating (due to build-up of fluids produced bytumor)
Lower abdominal and leg pain
Changes in bowel habits, such as constipation
Discomfort in the pelvis area
Nausea/indigestion
Quickly feeling full when eating
Sudden weight gain or loss
Unusual bleeding or discharge from the vagina
Risk Factor
Certain factors were identified that are associated with an increased risk of Ovarian cancer:
Beginning menstruation at an early age or starting menopause at a later age, or both, may increase the risk of ovarian cancer
Ovarian cancer can occur at any age butmore common in women above 60 years.
People with more affected close relatives have an increased risk.
Previous personal history of breast, uterine, or colorectal cancer.
Diagnosis
IMAGING TESTS
Tests, such as ultrasound or CT scans of abdomen and pelvis, may help determine the size, shape and ...
PELVIC EXAMINATION
Examination of the body to check general signs of health.During a pelvic exam, doctor visually exami...
Stages of Ovarian cancer
Stages of ovarian cancer span from Stage I to Stage IV
Stage 0
Cancer is presently only in the cells that line the oropharynx
Stage 1
Tumor is 2 cm or smaller and has not spread outside the oropharynx
Stage 2
Tumor is 2 cm or smaller and has not spread outside the oropharynx
Stage 3
Tumor is 2 cm or smaller and has not spread outside the oropharynx
Scale in centimetres
Tests for Ovarian Cancer
- Clinical Work up
- Department
Additional relevant tests
ONCOPRO HEREDITARY CANCER RISK PANEL
BRCA1 & BRCA2 MUTATION ADVANCED PANEL
BRCA1 & BRCA2 MUTATION COMPREHENSIVE PANEL
Diagnostic work up
IMMUNOHISTOCHEMISTRY: WT-1
IMMUNOHISTOCHEMISTRY: AFP (ALPHA FETO PROTEIN)
IMMUNOHISTOCHEMISTRY: INHIBIN
IMMUNOHISTOCHEMISTRY: CALRETININ
IMMUNOHISTOCHEMISTRY: CEA (CARCINOEMBRYONIC ANTIGEN)
IMMUNOHISTOCHEMISTRY: CDX-2
IMMUNOHISTOCHEMISTRY: MELAN-A
IMMUNOHISTOCHEMISTRY: HUMAN CHORIONIC GONADOTROPIN (HCG)
IMMUNOHISTOCHEMISTRY: Ber-Ep4 (EPCAM)
IMMUNOHISTOCHEMISTRY, PAX-8
IMMUNOHISTOCHEMISTRY: SALL 4
IMMUNOHISTOCHEMISTRY, CUSTOM PANEL
BRCA1 & BRCA2 MUTATION COMPREHENSIVE PANEL
ONCOPRO HEREDITARY CANCER RISK PANEL
BRCA1 & BRCA2 MUTATION ADVANCED PANEL
ANTI MULLERIAN HORMONE; AMH
CEA; CARCINO EMBRYONIC ANTIGEN
CA 125; OVARIAN CANCER MARKER
INHIBIN A, REPRODUCTIVE MARKER
HE4; HUMAN EPIDIDYMIS PROTEIN 4
INHIBIN B
ROMA; RISK OF OVARIAN MALIGNANCY ALGORITHM
OVARIAN CANCER PANEL
HISTOPATHOLOGY BIOPSY: SMALL SPECIMEN
GERM CELL TUMOR PANEL
IMMUNOHISTOCHEMISTRY: ESTROGEN RECEPTOR (ER)
COMPLETE BLOOD COUNT; CBC
IMMUNOHISTOCHEMISTRY, PROGESTERONE RECEPTOR (PR)
CYTOLOGY EXAMINATION BODY FLUIDS
IMMUNOHISTOCHEMISTRY: CYTOKERATIN (PANCYTOKERATIN)
IMMUNOHISTOCHEMISTRY: EPITHELIAL MEMBRANE ANTIGEN (EMA)
IMMUNOHISTOCHEMISTRY: CD117 (c-Kit)
HISTOPATHOLOGY BIOPSY: LARGE COMPLEX / CANCER SPECIMEN
IMMUNOHISTOCHEMISTRY: CYTOKERATIN- 7 (CK-7)
IMMUNOHISTOCHEMISTRY: CYTOKERATIN-20 (CK-20)
Follow up
ANTI MULLERIAN HORMONE; AMH
CEA; CARCINO EMBRYONIC ANTIGEN
CA 125; OVARIAN CANCER MARKER
INHIBIN A, REPRODUCTIVE MARKER
HE4; HUMAN EPIDIDYMIS PROTEIN 4
INHIBIN B
ROMA; RISK OF OVARIAN MALIGNANCY ALGORITHM
OVARIAN CANCER PANEL
GERM CELL TUMOR PANEL
ONCOPRO LIQUID BIOPSY
CANCER 50 GENE PANEL, NGS
BRCA1 & BRCA2 MUTATION DRUG PROFILING PANEL
Prognostic work up
IMMUNOHISTOCHEMISTRY: WT-1
IMMUNOHISTOCHEMISTRY: AFP (ALPHA FETO PROTEIN)
IMMUNOHISTOCHEMISTRY: INHIBIN
IMMUNOHISTOCHEMISTRY: CALRETININ
IMMUNOHISTOCHEMISTRY: CEA (CARCINOEMBRYONIC ANTIGEN)
IMMUNOHISTOCHEMISTRY: CDX-2
IMMUNOHISTOCHEMISTRY: MELAN-A
IMMUNOHISTOCHEMISTRY: HUMAN CHORIONIC GONADOTROPIN (HCG)
IMMUNOHISTOCHEMISTRY: Ber-Ep4 (EPCAM)
IMMUNOHISTOCHEMISTRY, PAX-8
IMMUNOHISTOCHEMISTRY: SALL 4
IMUNOHISTOCHEMISTRY: MICROSATELLITE INSTABILITY PANEL
IMMUNOHISTOCHEMISTRY, CUSTOM PANEL
CANCER 50 GENE PANEL, NGS
BRCA1 & BRCA2 MUTATION DRUG PROFILING PANEL
IMMUNOHISTOCHEMISTRY: ESTROGEN RECEPTOR (ER)
IMMUNOHISTOCHEMISTRY, PROGESTERONE RECEPTOR (PR)
IMMUNOHISTOCHEMISTRY: CYTOKERATIN (PANCYTOKERATIN)
IMMUNOHISTOCHEMISTRY: EPITHELIAL MEMBRANE ANTIGEN (EMA)
IMMUNOHISTOCHEMISTRY: CD117 (c-Kit)
IMMUNOHISTOCHEMISTRY: CYTOKERATIN- 7 (CK-7)
IMMUNOHISTOCHEMISTRY: CYTOKERATIN-20 (CK-20)
Screening
CYTOLOGY EXAMINATION BODY FLUIDS
CEA; CARCINO EMBRYONIC ANTIGEN
(CA) CYFRA 21-1; LUNG CANCER MARKER
Are you an Oncologist
Get in touch 
Are you a Patient or a Family Member of a Patient?
- Popular Tests
- Lab Test At Home
Get a call back within 15 minutes from our Health Advisor for Test Booking Assistance
© 2025 LalPathLabs.com. All rights reserved. ---v2.05.12.25.1
Follow us on:
- Popular Tests
- Lab Test At Home
Get a call back within 15 minutes from our Health Advisor for Test Booking Assistance
© 2025 LalPathLabs.com. All rights reserved.
---v2.05.12.25.1Follow us on: